Detalhe da pesquisa
1.
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
Proc Natl Acad Sci U S A
; 120(3): e2218899120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638211
2.
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].
PLoS Pathog
; 9(2): e1003157, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459315
3.
Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus.
J Virol
; 87(13): 7747-53, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23658441
4.
Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.
J Virol
; 87(16): 8826-42, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23785205
5.
Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice.
J Virol
; 86(14): 7637-49, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22573866
6.
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
PLoS Pathog
; 6(4): e1000823, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20369024
7.
Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.
J Exp Med
; 219(4)2022 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297953
8.
Genotype-specific neutralization and protection by antibodies against dengue virus type 3.
J Virol
; 84(20): 10630-43, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702644
9.
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.
J Virol
; 84(18): 9227-39, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20592088
10.
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
J Virol
; 81(23): 12816-26, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17881453
11.
The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.
mBio
; 4(6): e00873-13, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24255124
12.
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.
PLoS Negl Trop Dis
; 5(6): e1188, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21713020
13.
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.
Cell Host Microbe
; 8(3): 271-83, 2010 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20833378
14.
On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.
J Gen Virol
; 90(Pt 4): 799-809, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19264660
15.
Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype.
Virology
; 394(2): 175-82, 2009 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19833371
16.
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
Nat Struct Mol Biol
; 15(3): 312-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18264114
17.
The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence.
J Bacteriol
; 188(11): 3870-7, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707679
18.
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
J Virol
; 80(24): 12149-59, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17035317